A special roundtable discussion hosted by the National Association for Medical Direction of Respiratory Care will invite healthcare leaders to review and discuss how to reduce the risk of respiratory compromise.
The Rocky Mountain Hospital for Children in Denver is currently "packed with children" suffering from respiratory syncytial virus (RSV).
Children younger than 5 years of age accounted for 70% of pneumonia hospitalizations among children, at a cost of $1 billion per year, according to a CDC report.
RT Magazine discusses recent advances in humidification technology with Hal Norris, founder of ARC Medical.
A recent editorial argues that the industry trend of hospital consolidation is not necessarily a good thing for costs, patients, or the healthcare system at large.
Joe Toth has been promoted to vice president of Sales and Marketing for 3B Medical Inc, according to a company news announcement.
A total of 179 patients at Ronald Reagan UCLA Medical Center were exposed to Carbapenem-Resistant Enterobacteriaceae (CRE) during endoscopic procedures between October and January.
RT magazine's sister-publication Sleep Review will host a free webcast on pediatric sleep medicine on February 25 at 2 PM ET/11 AM PT.
A merging of wireless technology and medical care is still in its infancy, but health systems that began pilot programs with the technology in recent years say they see signs that it is keeping patients healthier.
Actavis has launched its generic version of AstraZeneca’s Pulmicort Respules after a US District Court judge in New Jersey denied AstraZeneca’s request for a permanent injunction and invalidated its patent.
National Health Service (NHS) England has issued a patient safety alert over the risk of severe harm and death from unintentional interruption of noninvasive ventilation (NIV).
HBO comedian John Oliver denounced tobacco company Philip Morris International and its global marketing tactics then suggested a new Marlboro mascot: "Jeff the Diseased Lung in a Cowboy Hat."
Results from a recent Johns Hopkins survey indicate that the role of hospital epidemiologists continues to grow, but many respondents do not believe there are enough resources and support to meet the increasing number of demands.
The American Academy of Allergy, Asthma & Immunology will host it's annual meeting on February 20-24, 2015 in Houston, TX.
CareFusion will be the exclusive US distributor for the Vivo by Breas line of life support and bi-level ventilators from Breas Medical.
Theravance and Mylan will partner to develop and commercialize their COPD drug, TD-4208.
Celtaxsys, Inc, a clinical stage biotechnology company, announced that the FDA has granted orphan drug designation to its cystic fibrosis treatment drug leukotriene A4 hydrolase inhibitor.
In a goal to bulk up its respiratory business, AstraZeneca has announced the acquisition of Actavis PLC's branded respiratory drug business in the US and Canada.
The COPD Foundation is currently seeking abstracts for its COPD9USA conference, to be held in Chicago in June. The deadline to submit abstracts is March 2, 2015.
The use of "patient navigators" can significantly reduce the overuse of emergency departments and the number of hospital readmissions, according to a recent study.